Kite Pharma Competitors and Similar CompaniesClear all

Novartis's competitors and similar companies include Juno Therapeutics and Adaptive Biotechnologies.
Novartis
Novartis
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
Juno Therapeutics
Juno Therapeutics
Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
Adaptive Biotechnologies
Adaptive Biotechnologies
Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease.
Founding Date
Founding Date
1996
Founding Date
2013
Founding Date
2009
Type
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Basel, CH HQ
Tirana, AL
Buenos Aires, AR
Macquarie Park, AU
Kundl, AT
Unterlangkampfen, AT
Wien, AT
see more
Locations
Seattle, US HQ
Göttingen, DE
Göttingen, DE
München, DE
München, DE
Bothell, US
Brisbane, US
Locations
Seattle, US HQ
New York, US
South San Francisco, US
Employees
Employees
75,883
Employees
1091% decrease
Employees
70910% decrease

Financial

Revenue (est.)
Revenue (est.)
$56.7b (FY, 2025)
Revenue (est.)
$111.9m (FY, 2017)
Revenue (est.)
$277m (FY, 2025)
Cost of goods
Cost of goods
$8.4b (FY, 2025)
Cost of goods
N/A
Cost of goods
$71.4m (FY, 2025)
Gross profit
Gross profit
$49.8b (FY, 2025)
Gross profit
N/A
Gross profit
$205.6m (FY, 2025)
Net income
Net income
$14b (FY, 2025)
Net income
($437.1m) (FY, 2017)
Net income
($59.5m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 6.5m
Total funding raised
$ 310m
Total funding raised
$ 525m
For sources of this data, please see the company profile

View Company Profiles

Juno Therapeutics
HQ
Seattle, US

Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.

View company
Adaptive Biotechnologies
HQ
Seattle, US
Employees
709↓ 10% decrease

Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease.

View company